-
(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-phenylcarbamate
-
ChemBase ID:
153858
-
Molecular Formular:
C20H23N3O2
-
Molecular Mass:
337.41552
-
Monoisotopic Mass:
337.17902699
-
SMILES and InChIs
SMILES:
C[C@@]12CCN([C@@H]1N(c1c2cc(cc1)OC(=O)Nc1ccccc1)C)C
Canonical SMILES:
O=C(Nc1ccccc1)Oc1ccc2c(c1)[C@]1(C)CCN([C@@H]1N2C)C
InChI:
InChI=1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1
InChIKey:
PBHFNBQPZCRWQP-QUCCMNQESA-N
-
Cite this record
CBID:153858 http://www.chembase.cn/molecule-153858.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-phenylcarbamate
|
|
|
IUPAC Traditional name
|
(3aS,8aR)-1,3a,8-trimethyl-2H,3H,8aH-pyrrolo[2,3-b]indol-5-yl N-phenylcarbamate
|
|
|
Synonyms
|
(-)-N-Phenylcarbamoyleseroline
|
1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-pyrrolo[2,3-b]indol-5-ol phenylcarbamate (ester)
|
Phenserine
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Donor
|
1
|
LogD (pH = 5.5)
|
3.1347353
|
LogD (pH = 7.4)
|
4.18858
|
Log P
|
4.2501016
|
Molar Refractivity
|
99.9552 cm3
|
Polarizability
|
37.64495 Å3
|
Polar Surface Area
|
44.81 Å2
|
Rotatable Bonds
|
3
|
Lipinski's Rule of Five
|
true
|
Acid pKa
|
12.859102
|
H Acceptors
|
4
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P0111
|
Biochem/physiol Actions (-)-Phenserine, a phenylcarbamate derivative, is a selective, non-competitive inhibitor of acetylcholinesterase (AChE). (-)-Phenserine produces rapid, potent, and long-lasting AChE inhibition, in vivo. It is significantly less toxic than (-)-physostigmine. (-)-Phenserine improves cognitive performance in both young learning-impaired and elderly rats. Reduced secretion of β-amyloid (Abeta) has been observed in cell lines exposed to (-)-phenserine, occurring through translational regulation of β-amyloid precursor protein (beta-APP) mRNA via a non-cholinergic mechanism. These in vitro findings appear to translate in vivo into animal models and humans. |
PATENTS
PATENTS
PubChem Patent
Google Patent